Ken Griffin’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.8M Sell
6,134,355
-4,196,411
-41% -$71.6M 0.01% 875
2025
Q4
$150M Buy
10,330,766
+5,312,905
+106% +$92.6M 0.02% 628
2025
Q3
$90M Buy
5,017,861
+3,573,942
+248% +$52.4M 0.01% 919
2025
Q2
$24.6M Buy
1,443,919
+773,814
+115% +$7.74M ﹤0.01% 1910
2025
Q1
$4.85M Sell
670,105
-799,273
-54% -$9.1M ﹤0.01% 3923
2024
Q4
$20.6M Buy
1,469,378
+282,651
+24% +$4.18M ﹤0.01% 2133
2024
Q3
$14.1M Buy
1,186,727
+1,167,983
+6,231% +$12.1M ﹤0.01% 2460
2024
Q2
$174K Sell
18,744
-5,257,076
-100% -$26.9M ﹤0.01% 10130
2024
Q1
$18.7M Buy
+5,275,820
New +$18.3M ﹤0.01% 2143

Other funds holding CORZ

Ken Griffin's CORZ Position: Q1 2026 in Review

Ken Griffin reduced its Core Scientific (CORZ) stake by 41% in Q1 2026, selling an estimated $71.6M and leaving 6,134,355 shares worth $91.8M. The position accounts for 0.01% of the portfolio, ranked #875.

Ken Griffin first reported a position in CORZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $150M in Q4 2025. 386 funds tracked by Wall St. Rank hold CORZ as of Q1 2026.

  • Ken Griffin held 6,134,355 shares of Core Scientific worth $91.8M as of Q1 2026.
  • Ken Griffin sold 4,196,411 Core Scientific shares in Q1 2026, an estimated $71.6M.
  • Core Scientific made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #875 holding.
  • Ken Griffin first reported a position in Core Scientific in Q1 2024 and has held it in 9 quarters since.
  • Ken Griffin's Core Scientific position peaked at $150M in Q4 2025.
  • 386 funds tracked by Wall St. Rank held Core Scientific as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.